ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 689627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 689627; 2) Community: the network communities that were significantly associated with the response to NSC 689627; 3) Molecule: the relationships between components within communities and NSC 689627; 4) MDR: the compounds that were significantly associated with the NSC 689627.

NSC Compound Enrichment Correlation
NSC 696073 Null 0.0329129886465387 0.33550891
NSC 699934 Null 0.0329129886465387 0.38769999
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0329129886465387 -0.05842176
NSC 709974 Null 0.0329129886465387 0.41393568
NSC 711077 Null 0.0329129886465387 0.42839411
NSC 718564 Null 0.0329129886465387 0.074240771
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0329129886465387 -0.025764589
NSC 720497 Null 0.0329129886465387 0.02663256
NSC 726217 Combretastatin A4-analogue 0.0329129886465387 0.3064854
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0329129886465387 0.42031915
Total:122  Current:93    [First] [Prev] [Next] [Last]